Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2025 Oct 10;20(10):e0334314. doi: 10.1371/journal.pone.0334314

Correction: New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Marta Malagón, Sara Ramió-Pujol, Marta Serrano, Joan Amoedo, Lia Oliver, Anna Bahí, Josep Oriol Miquel-Cusachs, Manel Ramirez, Xavier Queralt-Moles, Pau Gilabert, Joan Saló, Jordi Guardiola, Virginia Piñol, Mariona Serra-Pagès, Antoni Castells, Xavier Aldeguer, L Jesús Garcia-Gil
PMCID: PMC12513610  PMID: 41071749

There is an error in Table 2. The values in the Sensitivity (%), Specificity (%), PPV (%) and NPV (%) are incorrect. Please find the correct table below.

Table 2. Diagnostic performance of RAID-CRC Screen in the proof-of-concept study (n = 172).

Most advanced finding Groups used for calculating specificity Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Colorectal cancer (n = 11) NAA + NC 100.0 34.0 15.1 100.0
Advanced adenoma (n = 67) NAA + NC 95.5 34.0 50.8 91.4
Advanced neoplasia (n = 78) NAA + NC 96.2 34.0 54.7 91.4
Open in a new tab

Reference

  • 1.Malagón M, Ramió-Pujol S, Serrano M, Amoedo J, Oliver L, Bahí A, et al. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population. PLoS One. 2020;15(12):e0243158. doi: 10.1371/journal.pone.0243158 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLOS One are provided here courtesy of PLOS

RESOURCES